However, AFP has limited sensitivity and specificity, particularly in early-stage HCC, and false elevations can occur in conditions such as active hepatic inflammation (e.g., viral hepatitis) or other liver masses like cholangiocarcinoma (25). This evidence concerns the gene AFP and viral hepatitis.